Compare CCCC & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCCC | LOVE |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.3M | 177.7M |
| IPO Year | 2020 | 2018 |
| Metric | CCCC | LOVE |
|---|---|---|
| Price | $2.06 | $14.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $8.50 | ★ $27.60 |
| AVG Volume (30 Days) | ★ 1.4M | 617.3K |
| Earning Date | 11-06-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.90 |
| EPS | N/A | ★ 0.46 |
| Revenue | $30,108,000.00 | ★ $690,559,000.00 |
| Revenue This Year | N/A | $6.93 |
| Revenue Next Year | N/A | $7.52 |
| P/E Ratio | ★ N/A | $30.22 |
| Revenue Growth | N/A | ★ 0.13 |
| 52 Week Low | $1.09 | $11.26 |
| 52 Week High | $4.53 | $28.21 |
| Indicator | CCCC | LOVE |
|---|---|---|
| Relative Strength Index (RSI) | 34.91 | 54.02 |
| Support Level | $2.50 | $11.40 |
| Resistance Level | $2.69 | $14.48 |
| Average True Range (ATR) | 0.19 | 0.78 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 1.24 | 80.92 |
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.